Impact of High Intensity Contact Physical Activity During a Match on Echocardiographic Parameters and High-Sensitivity Troponin I in Competitive Rugby Players. [PDF]
Radic P+7 more
europepmc +1 more source
Impact of Food and Drug Administration Regulations on the Performance of Guideline-Recommended Pathways With an Approved Point-of-Care High-Sensitivity Cardiac Troponin I Assay. [PDF]
Koechlin L+11 more
europepmc +1 more source
In this study we utilized proteomic profiling to investigate mechanisms linked to the cancer‐inhibitory effect of cranberry proanthocyanidins (CPACs) on reflux‐induced esophageal adenocarcinoma in a rat model. The results indicate that CPAC inhibits cancer through targeting multiple hallmarks of cancer known to be dysregulated in progression to ...
Yun Zhang+7 more
wiley +1 more source
Enhancing lateral flow immunoassay performance for cardiac troponin I detection with pore-size tailored silica nanoparticles and smartphone-based "AdaptiScan" analysis. [PDF]
Ye S, Xu C, Li H, Feng S, Wang Y, Gao F.
europepmc +1 more source
ABSTRACT Introduction/Aims Sevasemten (EDG‐5506) is an orally administered, investigational small molecule that selectively modulates fast muscle fiber contraction by inhibiting fast myosin ATPase. This study assessed the safety, tolerability, and pharmacokinetics (PK)/pharmacodynamics (PD) of sevasemten in healthy adult volunteers (HVs) and adults ...
Joanne Donovan+11 more
wiley +1 more source
Serum Cardiac Troponin T Levels as a Therapy Response Marker in Tofersen‐Treated ALS
ABSTRACT Introduction/Aims Cardiac troponin T (cTnT) levels are elevated in the majority of persons with amyotrophic lateral sclerosis (ALS) and increase over time. Neurofilament light chain (NfL) is an established therapy response biomarker in ALS as superoxide dismutase1 (SOD1)‐ALS patients treated with the antisense oligonucleotide tofersen show a ...
Sarah Bernsen+7 more
wiley +1 more source
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk+5 more
wiley +1 more source
Case Report: Restrictive cardiomyopathy due to a rare mutation in troponin I gene (TNNI3) in a patient. [PDF]
Deng L, Luo L, Zhang M, Guo C, Liu K.
europepmc +1 more source
Transforming Niclosamide through Nanotechnology: A Promising Approach for Long COVID Management
This review highlights the transformation of niclosamide, a repurposed drug, through molecular science strategies to overcome its pharmacokinetic limitations. Emphasizing novel nanohybrid technologies and delivery platforms, the article explores their therapeutic potential in targeting the complex pathophysiology of long COVID, paving the way for ...
Sanoj Rejinold N+3 more
wiley +1 more source
Elevated Cardiac Troponin I Level Associated to Cardiac Dysfunction in Burned Patients. [PDF]
Segura C+6 more
europepmc +1 more source